A detailed history of Woodley Farra Manion Portfolio Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Woodley Farra Manion Portfolio Management Inc holds 323,100 shares of NVS stock, worth $33.7 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares
323,100
Previous 319,379 1.17%
Holding current value
$33.7 Million
Previous $34 Million 9.3%
% of portfolio
1.9%
Previous 1.86%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$106.13 - $120.89 $394,909 - $449,831
3,721 Added 1.17%
323,100 $37.2 Million
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $446,187 - $517,523
4,820 Added 1.53%
319,379 $34 Million
Q1 2024

May 10, 2024

SELL
$95.27 - $108.47 $10.5 Million - $11.9 Million
-109,768 Reduced 25.87%
314,559 $30.4 Million
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $1.6 Million - $1.76 Million
17,361 Added 4.27%
424,327 $42.8 Million
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $457,451 - $507,672
-4,829 Reduced 1.17%
406,966 $41.5 Million
Q2 2023

Aug 14, 2023

BUY
$92.52 - $104.91 $9.22 Million - $10.5 Million
99,616 Added 31.91%
411,795 $41.6 Million
Q1 2023

May 10, 2023

BUY
$80.03 - $92.81 $1.76 Million - $2.04 Million
21,991 Added 7.58%
312,179 $28.7 Million
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $235,716 - $288,662
3,120 Added 1.09%
290,188 $26.3 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $350,667 - $410,122
4,700 Added 1.66%
287,068 $21.8 Million
Q2 2022

Jul 22, 2022

BUY
$80.52 - $93.75 $566,216 - $659,250
7,032 Added 2.55%
282,368 $23.9 Million
Q1 2022

May 05, 2022

BUY
$80.11 - $90.62 $1.82 Million - $2.06 Million
22,765 Added 9.01%
275,336 $24.2 Million
Q4 2021

Feb 10, 2022

BUY
$79.7 - $88.13 $1.78 Million - $1.96 Million
22,296 Added 9.68%
252,571 $22.1 Million
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $206,821 - $240,609
-2,529 Reduced 1.09%
230,275 $18.8 Million
Q2 2021

Aug 10, 2021

SELL
$85.24 - $94.15 $7.31 Million - $8.08 Million
-85,772 Reduced 26.92%
232,804 $21.2 Million
Q1 2021

May 10, 2021

SELL
$83.5 - $98.47 $3.95 Million - $4.65 Million
-47,264 Reduced 12.92%
318,576 $27.2 Million
Q4 2020

Feb 05, 2021

BUY
$78.07 - $94.43 $296,119 - $358,172
3,793 Added 1.05%
365,840 $34.5 Million
Q3 2020

Nov 05, 2020

SELL
$82.14 - $91.0 $1.19 Million - $1.32 Million
-14,530 Reduced 3.86%
362,047 $31.5 Million
Q2 2020

Aug 12, 2020

BUY
$80.93 - $91.1 $262,132 - $295,072
3,239 Added 0.87%
376,577 $32.9 Million
Q1 2020

May 08, 2020

SELL
$70.67 - $99.01 $74,344 - $104,158
-1,052 Reduced 0.28%
373,338 $30.8 Million
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $417,363 - $471,890
4,948 Added 1.34%
374,390 $35.5 Million
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $33,275 - $36,667
-389 Reduced 0.11%
369,442 $32.1 Million
Q2 2019

Aug 12, 2019

BUY
$75.4 - $92.8 $273,023 - $336,028
3,621 Added 0.99%
369,831 $33.8 Million
Q1 2019

May 14, 2019

BUY
$75.32 - $86.15 $188,074 - $215,116
2,497 Added 0.69%
366,210 $35.2 Million
Q4 2018

Feb 12, 2019

SELL
$73.66 - $82.02 $297,954 - $331,770
-4,045 Reduced 1.1%
363,713 $31.2 Million
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $217,688 - $251,802
3,252 Added 0.89%
367,758 $31.7 Million
Q2 2018

Aug 13, 2018

BUY
$64.91 - $73.36 $259,964 - $293,806
4,005 Added 1.11%
364,506 $27.5 Million
Q1 2018

May 14, 2018

BUY
$70.39 - $84.15 $604,720 - $722,932
8,591 Added 2.44%
360,501 $29.1 Million
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $211,782 - $227,329
2,928 Added 0.84%
351,910 $29.5 Million
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $398,354 - $415,171
5,373 Added 1.56%
348,982 $30 Million
Q2 2017

Aug 11, 2017

BUY
N/A
343,609
343,609 $28.7 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Woodley Farra Manion Portfolio Management Inc Portfolio

Follow Woodley Farra Manion Portfolio Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodley Farra Manion Portfolio Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Woodley Farra Manion Portfolio Management Inc with notifications on news.